E-LIB Suche - Ergebnisse für: Ezponda, Ana

1

Impact of applying the global lung initiative criteria for ..:

Torres, J.P. (Juan P.) de ; Casanova, C. (Ciro) ; Marin, J.M. (José M.)...
https://hdl.handle.net/10171/68347. , 2024

Link: https://hdl.handle.net/1..

2

Cardiometabolic characterization in metabolic dysfunction–a..:

Perdomo, Carolina M ; Núñez Córdoba, Jorge M ; Ezponda, Ana...
Frontiers in Medicine, 9, 1023583.. , 2023

Link: https://idus.us.es/handl..

3

Safety, feasibility, and hemodynamic response of regadenoso..:

Muñiz-Sáenz-Diez, J. (Javier) ; Ezponda, A. (Ana) ; Caballeros, M. (Meylin)...
https://hdl.handle.net/10171/67912. , 2023

Link: https://hdl.handle.net/1..

4

Evaluation of miCRovascular rarefaction in vascUlar Cogniti..:

van-Dinther, M. (Maud) ; Bennett, J. (Jonathan) ; Thornton, G.D. (George D.)...
https://hdl.handle.net/10171/65970. , 2023

Link: https://hdl.handle.net/1..

5

Safety, feasibility, and hemodynamic response of regadenoso..:

Muñiz-Sáenz-Diez, Javier ; Ezponda, Ana ; Caballeros, Meylin...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10520095/. , 2023

Link: http://www.ncbi.nlm.nih...

6

Pneumatocele formation following COVID-19 pneumonia:

Sogbe, M. (Miguel) ; Madeleine-Di-Frisco, I. (I.) ; Ezponda, A. (Ana).
https://hdl.handle.net/10171/66797. , 2023

Link: https://hdl.handle.net/1..

7

Chest CT‐assessed comorbidities and all‐cause mortality ris..:

Ezponda, Ana ; Casanova, Ciro ; Divo, Miguel...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9303420/. , 2022

Link: http://www.ncbi.nlm.nih...

8

Cardiometabolic characterization in metabolic dysfunction-a..:

Perdomo, Carolina M ; Núñez-Córdoba, Jorge M ; Ezponda, Ana...
2296-858X. , 2022

Link: http://hdl.handle.net/10..

9

Assessment of splenic switch-off with arterial spin labelin..:

Aramendía-Vidaurreta, V. (Verónica) ; Solis-Barquero, S.M. (Sergio M.) ; Ezponda, A. (Ana)...
https://hdl.handle.net/10171/68285. , 2022

Link: https://hdl.handle.net/1..

10

Transient elastography and serum markers of liver fibrosis ..:

Perdomo, Carolina M ; Ezponda, Ana ; Núñez-Córdoba, Jorge M...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9023439/. , 2022

Link: http://www.ncbi.nlm.nih...

11

Cardiometabolic characterization in metabolic dysfunction-a..:

Perdomo-Zelaya, C.M. (Carolina M.) ; Nuñez-Cordoba, J.M. (Jorge M.) ; Ezponda, A. (Ana)...
https://hdl.handle.net/10171/64952. , 2022

Link: https://hdl.handle.net/1..

12

Table_1_Cardiometabolic characterization in metabolic dysfu..:

Perdomo, Carolina M ; Núñez-Córdoba, J.M ; Ezponda, Ana...
Perdomo, Carolina M.; Núñez-Córdoba, J.M.; Ezponda, Ana; Mendoza, Francisco J.; Ampuero, Javier; Bastarrika, Gorka; Frühbeck, Gema; Escalada, Javier. Cardiometabolic characterization in metabolic dysfunction-associated fatty liver disease. https://doi.org/10.3389/fmed.2022.1023583 . http://hdl.handle.net/10261/304037. , 2022

Link: http://hdl.handle.net/10..

13

Cardiometabolic characterization in metabolic dysfunction-a..:

Perdomo, Carolina M ; Núñez-Córdoba, J.M ; Ezponda, Ana...
Publisher's version. , 2022

Link: http://hdl.handle.net/10..

14

Chest CT-assessed comorbidities and all-cause mortality ris..:

Ezponda, A. (Ana) ; Casanova, C. (Ciro) ; Divo, M. (Miguel)...
https://hdl.handle.net/10171/63761. , 2022

Link: https://hdl.handle.net/1..

15

Cardiometabolic characterization in metabolic dysfunction–a..:

Perdomo, Carolina M ; Núñez-Córdoba, Jorge M ; Ezponda, Ana...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9632176/. , 2022

Link: http://www.ncbi.nlm.nih...